Targeting the Intestinal Microbiota to Prevent Type 2 Diabetes and Enhance the Effect of Metformin on Glycaemia: A Randomised Controlled Pilot Study

Early treatment may prevent or delay the onset of type 2 diabetes mellitus (T2DM) in individuals who are at high risk. Lifestyle interventions and the hypoglycemic drug metformin have been shown to reduce T2DM incidence. The effectiveness of such interventions may be enhanced by targeting environmen...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Talia Palacios, Luis Vitetta, Samantha Coulson, Claire D. Madigan, Yan Y. Lam, Rachel Manuel, David Briskey, Chelsea Hendy, Ji-Nu Kim, Thomas Ishoey, Maria J. Soto-Giron, Eric M. Schott, Gerardo Toledo, Ian D. Caterson
Format: Artigo
Jezik:Inglês
Izdano: MDPI AG 2020-07-01
Serija:Nutrients
Teme:
prediabetes
type 2 diabetes mellitus
metformin
intestinal microbiota
probiotics
short-chain fatty acids
Online pristup:https://www.mdpi.com/2072-6643/12/7/2041
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items